Skip to main content
. 2008 Oct 24;29(4):334–341. doi: 10.1159/000166598

Table 1.

Participant characteristics

Characteristic Cases (n = 207) Controls (n = 207) p value
Age, years 74.1 ± 6.1 73.9 ± 5.9 0.71
Females 99 (47.8) 99 (47.8) 1.00
Race 1.00
 White 200 (96.6) 200 (96.6)
 Black 6 (2.9) 6 (2.9)
American Indian/Alaskan native 1 (0.5) 1 (0.5)
Diabetes status 0.99
 Normal glucose 123 (59.4) 123 (59.4)
 Impaired fasting glucose 30 (14.5) 29 (14.0)
 Diabetes 54 (26.1) 55 (26.6)
CVD 68 (33) 49 (24) 0.04
Congestive heart failure 15 (7) 8 (4) 0.13
Internal carotid IMT <0.001
 Median 1.46 1.30
 IQR 1.11–1.92 0.94–1.65
Current Smoking 24 (11.6) 19 (9.2) 0.57
Systolic blood pressure, mm Hg 142.6 ± 22.9 136.9 ± 22.8 0.01
Diastolic blood pressure, mm Hg 70.8 ± 12.4 70.1 ± 11.4 0.56
HTN medication (excluding diuretics) 84 (40.6) 68 (33) 0.10
Diuretics 82 (40) 60 (29) 0.02
Weight, kg 75.7 ± 14.5 75.0 ± 14.9 0.64
Change in weight, lbs −2.9 ± 11.6 −1.5 ± 9.7 0.19
Waist circumference, cm 97.3 ± 12.8 95.7 ± 12.9 0.20
Change in waist circumference, cm 2.5 ± 7.5 2.8 ± 7.4 0.63
Estimated GFR, ml/min/1.73 m2 67.2 ± 23.6 66.9 ± 22.6 0.925
Baseline creatinine, mg/dl 1.13 ± 0.43 1.13 ± 0.42 0.95
Change in creatinine, mg/dl 0.4 ± 0.51 (0.3 to 6.8) −0.03 ± 0.10 (−0.50 to 0.20) <0.001
Baseline cystatin C, mg/dl 1.18 ± 0.38 1.09 ± 0.33 0.03
Change in cystatin C, mg/dl 0.48 ± 0.48 0.08 ± 0.13 <0.001

Figures in parentheses indicate percentages or interquartile range.